Gene expression and mitotic exit induced by microtubule-stabilizing drugs.
暂无分享,去创建一个
[1] R. Jove,et al. Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis. , 2003, Cancer research.
[2] Mary Helen Barcellos-Hoff,et al. Transforming growth factor-beta1 mediates cellular response to DNA damage in situ. , 2002, Cancer research.
[3] M. Blagosklonny. Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs , 2002, Oncogene.
[4] S. Elledge,et al. Bub2 Is a Cell Cycle Regulated Phospho-Protein Controlled by Multiple Checkpoints , 2002, Cell cycle.
[5] H. Broxmeyer,et al. P21waf-1-Chk1 Pathway Monitors G1 Phase Microtubule Integrity and Is Crucial for Restriction Transition , 2002, Cell cycle.
[6] T. Fojo,et al. Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[7] D. Altieri,et al. A p34(cdc2) survival checkpoint in cancer. , 2002, Cancer cell.
[8] V. Tron,et al. GADD45 regulates G2/M arrest, DNA repair, and cell death in keratinocytes following ultraviolet exposure. , 2002, The Journal of investigative dermatology.
[9] S. Mani,et al. Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase I clinical study. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] A. Valette,et al. PP1 phosphatase is involved in Bcl-2 dephosphorylation after prolonged mitotic arrest induced by paclitaxel. , 2002, Biochemical and biophysical research communications.
[11] S. Horwitz,et al. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. , 2002, Cancer research.
[12] S. de Jong,et al. Fas receptor‐mediated apoptosis: a clinical application? , 2002, The Journal of pathology.
[13] M. Lotze,et al. TRAIL, Fasl and a blocking anti‐DR5 antibody augment paclitaxel‐induced apoptosis in human non‐small‐cell lung cancer , 2002, International journal of cancer.
[14] T. Fojo,et al. Paclitaxel-Induced FasL-Independent Apoptosis and Slow (Non-Apoptotic) Cell Death , 2002, Cancer biology & therapy.
[15] J. Manfredi,et al. Multiple roles of the tumor suppressor p53 , 2002, Current opinion in oncology.
[16] M. Rajeevan,et al. Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. , 2001, Methods.
[17] S. Kaufmann,et al. A multistep model for paclitaxel-induced apoptosis in human breast cancer cell lines. , 2001, Experimental cell research.
[18] U. Klar,et al. Subcellular distribution of epothilones in human tumor cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] F. Zunino,et al. Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells , 2001, The Prostate.
[20] T. Fojo,et al. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity , 2001, Oncogene.
[21] K. Vousden,et al. Regulation and function of the p53 tumor suppressor protein. , 2001, Current opinion in cell biology.
[22] G. Getz,et al. DNA microarrays identification of primary and secondary target genes regulated by p53 , 2001, Oncogene.
[23] G. Stark,et al. Regulation of the G2/M transition by p53 , 2001, Oncogene.
[24] H. Saya,et al. Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines , 2001, Oncogene.
[25] J. Pietenpol,et al. Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner , 2001, Oncogene.
[26] B. Kennedy,et al. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. , 2000, Genes & development.
[27] S. Arkin,et al. Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle. , 2000, Cancer research.
[28] K. Vousden,et al. Stress Signals Utilize Multiple Pathways To Stabilize p53 , 2000, Molecular and Cellular Biology.
[29] D. Notterman,et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. , 2000, Genes & development.
[30] Meek Dw. The role of p53 in the response to mitotic spindle damage. , 2000 .
[31] D. Guardavaccaro,et al. Arrest of G1-S Progression by the p53-Inducible Gene PC3 Is Rb Dependent and Relies on the Inhibition of Cyclin D1 Transcription , 2000, Molecular and Cellular Biology.
[32] K. Guan,et al. PTGF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway , 2000 .
[33] D. Meek. The role of p53 in the response to mitotic spindle damage. , 2000, Pathologie-biologie.
[34] G. Peters,et al. Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[35] G. Wahl,et al. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses , 1999, Oncogene.
[36] K. Kinzler,et al. Identification and classification of p53-regulated genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[37] Z. Zong,et al. Lack of synchrony among multiple nuclei induces partial DNA fragmentation in V79 cells polyploidized by demecolcine , 1999, Cell proliferation.
[38] G. Stark,et al. Mechanisms of G2 arrest in response to overexpression of p53. , 1999, Molecular biology of the cell.
[39] T. Fojo,et al. Molecular effects of paclitaxel: Myths and reality (a critical review) , 1999, International journal of cancer.
[40] P Ubezio,et al. Measuring the complexity of cell cycle arrest and killing of drugs: kinetics of phase-specific effects induced by taxol. , 1999, Cytometry.
[41] T. K. Yeung,et al. The mode of action of taxol: apoptosis at low concentration and necrosis at high concentration. , 1999, Biochemical and biophysical research communications.
[42] M. Kirsch‐Volders,et al. p53-independent apoptosis and p53-dependent block of DNA rereplication following mitotic spindle inhibition in human cells. , 1999, Experimental cell research.
[43] P. Sorger,et al. Retention of the BUB3 checkpoint protein on lagging chromosomes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[44] D. Banerjee,et al. Overexpression of p21(waf1) decreases G2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein. , 1999, Molecular pharmacology.
[45] P Wadsworth,et al. Taxol suppresses dynamics of individual microtubules in living human tumor cells. , 1999, Molecular biology of the cell.
[46] E. Solary,et al. Fas Ligand-independent, FADD-mediated Activation of the Fas Death Pathway by Anticancer Drugs* , 1999, The Journal of Biological Chemistry.
[47] S. Leach,et al. p21Waf1/Cip1 Inhibition of Cyclin E/Cdk2 Activity Prevents Endoreduplication after Mitotic Spindle Disruption , 1999, Molecular and Cellular Biology.
[48] B. Pollock. Obstacles and opportunities for the use of health‐related quality‐of‐life assessment in pediatric cancer clinical trials (discussion) , 1999, International journal of cancer. Supplement = Journal international du cancer. Supplement.
[49] G. Stark,et al. Mechanisms of G 2 Arrest in Response to Overexpression of p 53 , 1999 .
[50] D. Israeli,et al. p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs , 1998, The Journal of experimental medicine.
[51] Jun Yao,et al. Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. , 1998, Molecular cell.
[52] S. Horwitz,et al. Mechanisms of Taxol-induced cell death are concentration dependent. , 1998, Cancer research.
[53] R. Himes,et al. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action , 1998 .
[54] A Elhajouji,et al. Spindle poisons can induce polyploidy by mitotic slippage and micronucleate mononucleates in the cytokinesis-block assay. , 1998, Mutagenesis.
[55] S. Jee,et al. Taxol-induced p34cdc2 kinase activation and apoptosis inhibited by 12-O-tetradecanoylphorbol-13-acetate in human breast MCF-7 carcinoma cells. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[56] V. Baldin,et al. Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line , 1997, Oncogene.
[57] A. Hyman,et al. Coupling cell division and cell death to microtubule dynamics. , 1997, Current opinion in cell biology.
[58] M. Bornens,et al. Pulse treatment of interphasic HeLa cells with nanomolar doses of docetaxel affects centrosome organization and leads to catastrophic exit of mitosis. , 1997, Journal of cell science.
[59] P. Giannakakou,et al. Activities of the Microtubule-stabilizing Agents Epothilones A and B with Purified Tubulin and in Cells Resistant to Paclitaxel (Taxol®)* , 1997, The Journal of Biological Chemistry.
[60] G. Shah,et al. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[61] C. Prives,et al. p53: puzzle and paradigm. , 1996, Genes & development.
[62] G. Demers,et al. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis , 1996, Nature Medicine.
[63] D. Burke,et al. Checkpoint genes required to delay cell division in response to nocodazole respond to impaired kinetochore function in the yeast Saccharomyces cerevisiae , 1995, Molecular and cellular biology.
[64] C. Norbury,et al. Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. , 1995, Trends in biochemical sciences.
[65] E. Lazarides,et al. Taxol-Induced Mitotic Block Triggers Rapid Onset of a p53-Independent Apoptotic Pathway , 1995, Molecular medicine.
[66] E. Lazarides,et al. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. , 1995, Cancer research.
[67] R. Margolis,et al. Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells , 1994, The Journal of cell biology.
[68] P. Kiener,et al. Activation of p34cdc2 coincident with taxol-induced apoptosis. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[69] R. Schimke,et al. Life, death and genomic change in perturbed cell cycles. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[70] M. Jordan,et al. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[71] R. Schimke,et al. Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[72] P. Schiff,et al. Taxol stabilizes microtubules in mouse fibroblast cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[73] P. Schiff,et al. Promotion of microtubule assembly in vitro by taxol , 1979, Nature.